BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence
Association of the brain-derived neurotrophic factor (BDNF) genetic polymorphism rs6265 (Val66Met) with methamphetamine (METH) dependence and METH-induced psychosis was investigated in the Thai population. The rs6265 genotype was determined in 100 male METH-dependent subjects and 102 controls using...
Saved in:
Published in | Pharmacogenomics Vol. 16; no. 14; pp. 1541 - 1545 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Future Medicine Ltd
01.09.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Association of the brain-derived neurotrophic factor (BDNF) genetic polymorphism rs6265 (Val66Met) with methamphetamine (METH) dependence and METH-induced psychosis was investigated in the Thai population.
The rs6265 genotype was determined in 100 male METH-dependent subjects and 102 controls using a real-time PCR high-resolution melt (RT-PCR-HRM) assay.
The rs6265 genotype demonstrated significant differences in distribution between METH-dependent subjects and controls in which the frequency of GG genotype versus A-allele carriers was associated with METH dependence. Moreover, a significant effect of genotype on the occurrence of psychosis was found, with a lower frequency of GG genotype associated with METH-induced psychosis.
The present findings indicate that rs6265 is associated with METH dependence in the Thai population, with the GG genotype greater in METH-dependent subjects but reducing the emergence of METH-dependent psychosis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1462-2416 1744-8042 1744-8042 |
DOI: | 10.2217/pgs.15.96 |